With reference to established NK-cell immunobiology, this phenotypic switch appears consistent with expansion of tumour-reactive activated effector CD16brightCD56dim NK-cells by maturation from the pool of nodal CD56brightCD16dim NK-cells undergoing education and licensing of “self”-receptors such as NKG2A (26, 27). The gene discussed is KLRC1; the disease is neoplasm.